Michael J Higgins Net Worth & Insider Trades
Michael J Higgins - Chief Operating Officer, Ironwood Pharmaceuticals Inc
What is Michael J Higgins's Net Worth?
The current estimated net worth of Ironwood Pharmaceuticals Inc's Chief Operating Officer, Michael J Higgins, is estimated to be about $6.48M . Michael J Higgins owns about 125,000 units of Ironwood Pharmaceuticals Inc common stock. In the last 3 months at Ironwood Pharmaceuticals Inc, Michael J Higgins has sold an estimated value of $398.5K worth.
What is Michael J Higgins's Past Insider Trading?
Michael J Higgins's largest sale order was 25,000 units , worth over $398.5K on June 28, 2011. In total, Michael J Higgins has made about 2 transactions over 3 months of their time at Ironwood Pharmaceuticals Inc. Michael J Higgins usually trades in September and June, with the busiest year in 2011.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Michael Higgins
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Michael J Higgins's Salary in 2020?
As Chief Operating Officer of Ironwood Pharmaceuticals Inc, Michael J Higgins has a total base salary of $464,681 . Michael J Higgins received compensation valued at about $1,891,310 in 2020 after becoming Chief Operating Officer. The vast majority of their compensation came in the form of a bonus of $100,000 , stock awards of $1,121,001 , other earnings, plans or compensations of $194,558 , and other compensation of $11,040 .
What is Michael J Higgins's' Mailing Address?
- Mailing address is C/o Genocea Biosciences, Inc. 100 Acorn Park Drive, 5th Floor Cambridge MA 02140 MA
Ironwood Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mark Mallon* | 2020 | $801,173 | - | $5,423,731 | - | $585,169 | $11,040 | $6,821,113 |
| Mark Mallon* | 2019 | $750,000 | $880,000 | $3,692,810 | $3,804,331 | $797,063 | $144,596 | $10,068,800 |
| Mark Mallon* | 2018 | - | - | - | - | - | - | - |
| Gina Consylman | 2020 | $512,751 | - | $1,676,402 | - | $264,652 | $11,040 | $2,464,845 |
| Gina Consylman | 2019 | $480,000 | $250,000 | $1,467,731 | $888,546 | $358,800 | $8,502 | $3,453,579 |
| Gina Consylman | 2018 | $415,000 | - | $782,385 | $501,764 | $207,500 | $8,040 | $1,914,688 |
| Thomas McCourt* | 2020 | $576,120 | - | $2,465,327 | - | $357,409 | $11,040 | $3,409,896 |
| Thomas McCourt* | 2019 | $511,250 | - | $1,760,143 | $2,370,159 | $454,272 | $8,502 | $5,104,327 |
| Thomas McCourt* | 2018 | $465,000 | - | $549,641 | $869,479 | $232,500 | $34,002 | $2,150,622 |
| Jason Rickard | 2020 | $473,314 | - | $1,479,191 | - | $258,338 | $11,040 | $2,221,883 |
| Jason Rickard | 2019 | - | - | - | - | - | - | - |
| Jason Rickard | 2018 | - | - | - | - | - | - | - |
| Michael Shetzline, M.D., Ph.D. | 2020 | $464,681 | $100,000 | $1,121,001 | - | $194,558 | $11,040 | $1,891,310 |
| Michael Shetzline, M.D., Ph.D. | 2019 | - | - | - | - | - | - | - |
| Michael Shetzline, M.D., Ph.D. | 2018 | - | - | - | - | - | - | - |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1446847/000104746921001006/a2243150zdef14a.htm
What are Ironwood Pharmaceuticals Inc's Past Insider Trades?
Ironwood Pharmaceuticals Inc's most recent insider trade came on November 22, 2023 by Andrew Davis who sold 3,287 units worth $31.85K . In the last 13 years, insiders at Ironwood Pharmaceuticals Inc have sold an estimated value of $119.46M and bought an estimated value of $42.4M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Mark Currie, Director, Thomas McCourt, Chief Executive Officer, and Bryan E Roberts, Director .
IRONWOOD PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||